TIMP1 and glioblastoma: Most importantly, silencing TIMP1 effectively restored sensitivity to TMZ (chemosensitization).<h4>Conclusions</h4>This study establishes and validates a robust GBM prognostic model integrating the sphingolipid-associated molecular landscape with chemotherapy resistance.